These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7592759)

  • 1. The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.
    Mouillac B; Chini B; Balestre MN; Elands J; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Jard S; Barberis C
    J Biol Chem; 1995 Oct; 270(43):25771-7. PubMed ID: 7592759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of agonist binding sites of vasopressin and oxytocin receptors.
    Mouillac B; Chini B; Balestre MN; Jard S; Barberis C; Manning M; Tribollet E; Trumpp-Kallmeyer S; Hoflack J; Elands J
    Adv Exp Med Biol; 1995; 395():301-10. PubMed ID: 8713980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
    Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M
    Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
    Chini B; Mouillac B; Ala Y; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M; Jard S
    EMBO J; 1995 May; 14(10):2176-82. PubMed ID: 7774575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
    Postina R; Kojro E; Fahrenholz F
    Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding.
    Cotte N; Balestre MN; Aumelas A; Mahé E; Phalipou S; Morin D; Hibert M; Manning M; Durroux T; Barberis C; Mouillac B
    Eur J Biochem; 2000 Jul; 267(13):4253-63. PubMed ID: 10866830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
    Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
    J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.
    Rodrigo J; Pena A; Murat B; Trueba M; Durroux T; Guillon G; Rognan D
    Mol Endocrinol; 2007 Feb; 21(2):512-23. PubMed ID: 17082326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists.
    Hawtin SR; Wesley VJ; Parslow RA; Simms J; Miles A; McEwan K; Wheatley M
    Mol Endocrinol; 2002 Mar; 16(3):600-9. PubMed ID: 11875119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.
    Acharjee S; Do-Rego JL; Oh DY; Ahn RS; Choe H; Vaudry H; Kim K; Seong JY; Kwon HB
    J Biol Chem; 2004 Dec; 279(52):54445-53. PubMed ID: 15475353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.
    Chini B; Mouillac B; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Andriolo M; Pupier S; Jard S; Barberis C
    FEBS Lett; 1996 Nov; 397(2-3):201-6. PubMed ID: 8955347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.
    Hawtin SR; Wesley VJ; Parslow RA; Patel S; Wheatley M
    Biochemistry; 2000 Nov; 39(44):13524-33. PubMed ID: 11063589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonists.
    Manning M; Cheng LL; Stoev S; Klis W; Nawrocka E; Olma A; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1997; 3(1):31-46. PubMed ID: 9230469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors.
    Tahtaoui C; Balestre MN; Klotz P; Rognan D; Barberis C; Mouillac B; Hibert M
    J Biol Chem; 2003 Oct; 278(41):40010-9. PubMed ID: 12869559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.
    Busnelli M; Bulgheroni E; Manning M; Kleinau G; Chini B
    J Pharmacol Exp Ther; 2013 Aug; 346(2):318-27. PubMed ID: 23723434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An arginyl in the N-terminus of the V1a vasopressin receptor is part of the conformational switch controlling activation by agonist.
    Hawtin SR; Wesley VJ; Simms J; Parslow RA; Miles A; McEwan K; Keen M; Wheatley M
    Eur J Biochem; 2003 Dec; 270(23):4681-8. PubMed ID: 14622255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat testicular myoid cells express vasopressin receptors: receptor structure, signal transduction, and developmental regulation.
    Howl J; Rudge SA; Lavis RA; Davies AR; Parslow RA; Hughes PJ; Kirk CJ; Michell RH; Wheatley M
    Endocrinology; 1995 May; 136(5):2206-13. PubMed ID: 7536665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
    Sugimoto T; Saito M; Mochizuki S; Watanabe Y; Hashimoto S; Kawashima H
    J Biol Chem; 1994 Oct; 269(43):27088-92. PubMed ID: 7929452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.